Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation

Alexander V. Babiy*, Janusz M. Gebicki, David R. Sullivan, Karen Willey

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    92 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation'. Together they form a unique fingerprint.

    Chemistry

    Medicine & Life Sciences